N-Acetyl-L-Cysteine

Spezifikationen

616-91-1CAS-Nummer

210-498-3EG-Nummer

(2R)-2-acetamido-3-sulfanylpropanoic acidIUPAC-Name

C5H9NO3SChemische Formel

163.2 g/molMolekulargewicht

N-Acetyl-L-cysteine; acetylcysteine; 616-91-1; N-Acetylcysteine; mercapturic acid; Acetadote; L-Acetylcysteine; Fluimucetin; Respaire; N-Acetyl cysteine; Acetilcisteina; Brunac; Acetylcysteinum; Syntemucol; Tixair; L-Cysteine, N-acetyl-; Mucolyticum-Lappe; N-Acetyl-3-mercaptoalanine; Mucolyticum; Cetylev; (2R)-2-acetamido-3-sulfanylpropanoic acid; Neo-fluimucil; Cysteine, N-acetyl-, L-; N-Acetyl-L-(+)-cysteine; Mercapturic acid, (R)-; Fluatox; Fluimicil; Mucolator; Mucret; (R)-mercapturic acid; Oristar nalc; MUCOSIL-10; MUCOSIL-20; N-acetyi-l-cysteine; L-alpha-Acetamido-beta-mercaptopropionic acid; Mucocedyl; NSC-111180; DTXSID5020021; WYQ7N0BPYC; Muco sanigen; DTXCID4021; (R)-2-acetylamino-3-mercaptopropanoic acid; (2R)-2-acetylamino-3-sulfanylpropanoic acid; CHEBI:28939; NSC111180; DTXSID8048105; Jenapharm; Yournac; Bromuc; BronchoFips; Genac; Siran; Fluimucil long; MPectil; Fluimucil n; Broncho Fips; Respi-nac; N Acetylcysteine; Mucopect, Dampo; M Pectil; Sanigen, Muco; En-cys; Larylin NAC; Acid, Mercapturic; NAC Zambon; A-cys; NAC, Bisolvon; Tris-NAC; Zambon, NAC; Fluimucil 600; Zinc, Acetylcysteine; N Acetyl L cysteine; Oronac 600; Sodium, Acetylcysteine; Acetylcysteine Solution; Acetylcystein, mentopin; Acetylcysteine Injection; RefChem:6371; NAC AL; CorniSol Eye Wash Drops; Acc-600; Hydrochloride, Acetylcysteine; Monosodium Salt Acetylcysteine; Acetylcysteine, Monosodium Salt; Monoammonium Salt Acetylcysteine; DTXCID6028076; CHEBI:22198; R05CB01; S01XA08; V03AB23; 210-498-3; Broncholysin; Mucomyst; Parvolex; Fluimucil; Acetein; N-Acetyl-cysteine; Airbron; Flumucetin; Mucosolvin; Fluprowit; Mucofilin; Mucosil; Fabrol; Inspir; Fluimicil Infantil; Lysomucil; acetyl cysteine; Ac-Cys-OH; Mucolyticum Lappe; Mucolytikum Lappe; (R)-2-Acetamido-3-mercaptopropanoic acid; Acetyl-L-cysteine; Exomuc; NAC-TB; component of Naxid; MFCD00004880; (2R)-2-Acetamido-3-sulfanyl-propanoic acid; C5H9NO3S; NSC 111180; N-acetyl-(R)-cysteine; cysteine, N-acetyl-; RK-0202; MLS000028419; NCGC00022304-05; SMR000058377; Flumil; N-acetylcystein; Acetylcysteinum [INN-Latin]; CAS-616-91-1; Acetilcisteina [INN-Spanish]; CCRIS 3764; HSDB 3003; SR-01000075439; UNII-WYQ7N0BPYC; EINECS 210-498-3; Ilube; AcCys; s1623; N-acetyl-l-cys; Sodium 2-acetamido-3-mercaptopropionate; Acetylcysteine CRS; SC2; Ilube (eye drops); N-A-C Sustain; N-acetyl-L-cystein; Naxid (Salt/Mix); N-Acety-L-Cysteine; (r)-n-acetylcysteine; Acetylcysteine [USAN:USP:INN:BAN:JAN]; Opera_ID_452; MUCOMYST (TN); Spectrum2_000086; Spectrum3_000287; Spectrum4_000137; Spectrum5_000764; AC-L-CYS-OH; Acetylcysteine (Standard); CHEMBL600; NAC & TNF; ACETYLCYSTEINE [II]; ACETYLCYSTEINE [MI]; SCHEMBL5292; ACETYLCYSTEINE [INN]; ACETYLCYSTEINE [JAN]; Lopac0_000081; ACETYLCYSTEINE [HSDB]; ACETYLCYSTEINE [USAN]; BSPBio_001794; KBioGR_000554; MLS001076125; MLS006011563; ACETYLCYSTEINE [VANDF]; SPECTRUM1500105; SPBio_000012; ACETYLCYSTEINE [MART.]; orb1310210; SCHEMBL1360912; ACETYLCYSTEINE [USP-RS]; ACETYLCYSTEINE [WHO-DD]; Acetylcysteine(N-acetylcysteine); GTPL10945; HY-B0215R; KBio3_001294; N-Acetyl-L-cysteine, USP grade; MSK8340; Acetylcysteine (JP18/USP/INN); GLXC-15143; HMS1920A11; HMS2091G11; HMS2234J22; HMS3260A04; HMS3655G11; HMS3715D03; HMS3884E04; HMS6018L22; HY-B0215; 2-Acetylamino-3-mercapto-propionate; ACETYLCYSTEINE [ORANGE BOOK]; Tox21_110877; Tox21_201078; Tox21_500081; acetylcysteine (n-acetyl-l-cysteine); ACETYLCYSTEINE [EP MONOGRAPH]; BDBM50420190; CCG-38902; EBC-11098; ACETYLCYSTEINE [USP MONOGRAPH]; AKOS015841009; Tox21_110877_1; CCG-204176; DB06151; FA10890; GS-3121; LP00081; SDCCGSBI-0050069.P002; (R)-2-Acetamido-3-mercaptopropanoicacid; NCGC00015086-04; NCGC00022304-03; NCGC00022304-04; NCGC00022304-06; NCGC00022304-07; NCGC00022304-08; NCGC00022304-16; NCGC00022304-17; NCGC00022304-21; NCGC00022304-23; NCGC00258631-01; NCGC00260766-01; AC-16071; AC-24117; BP-12854; FA138512; SY009511; propanoic acid, 2-acetylamino-3-mercapto-; SBI-0051272.P003; DB-038288; A0905; A0918; EU-0100081; NS00069131; ST50824849; SW199597-2; (2R)-2-acetylamino-3-mercapto-propionic acid; EN300-72028; (2R)-2-(acetylamino)-3-sulfanylpropanoic acid; A 7250; C06809; D00221; L-Cysteine, N-acetyl- & Tumor necrosis factor; N-Acetyl-L-cysteine, BioXtra, >=99% (TLC); AB00051908_02; AB00382974-12; AB00382974_13; F003631; L-.alpha.-Acetamido-.beta.-mercaptopropionic acid; N-Acetyl-L-cysteine 100 |Ig/mL in Acetonitrile; Q375613; N-Acetyl-L-cysteine & Tumor necrosis factor (TNF); N-Acetyl-L-cysteine 100 microg/mL in Acetonitrile; SR-01000075439-1; SR-01000075439-3; SR-01000075439-5; BRD-K59058747-001-18-3; BRD-K59058747-001-19-1; BRD-K59058747-001-20-9; N-Acetyl-L-cysteine - Non-animal and non-human origin; N-Acetyl-L-cysteine, cell culture tested, BioReagent; N-Acetyl-L-cysteine, Vetec(TM) reagent grade, 98%; F1905-7178; Z1143441555; CABC898A-E48B-4E13-9F72-98D0609A1854; N-Acetyl-L-cysteine, SAJ special grade, 98.0-102.0%; N-Acetyl-L-cysteine, Sigma Grade, >=99% (TLC), powder; Acetylcysteine, British Pharmacopoeia (BP) Reference Standard; Acetylcysteine, European Pharmacopoeia (EP) Reference Standard; Acetylcysteine, United States Pharmacopeia (USP) Reference Standard; N-Acetyl-L-cysteine, Pharmaceutical Secondary Standard; Certified Reference MaterialSynonyme